Pro Medicus Limited (ASX:PME – Get Free Report) insider Alice Williams acquired 125 shares of the business’s stock in a transaction dated Friday, February 14th. The shares were acquired at an average cost of A$272.69 ($173.69) per share, with a total value of A$34,086.00 ($21,710.83).
Pro Medicus Stock Performance
The firm has a market capitalization of $29.16 billion, a PE ratio of 351.99, a price-to-earnings-growth ratio of 3.87 and a beta of 0.56. The company has a current ratio of 5.98, a quick ratio of 4.39 and a debt-to-equity ratio of 1.10.
Pro Medicus Increases Dividend
The company also recently disclosed a Interim dividend, which will be paid on Thursday, March 20th. Stockholders of record on Thursday, March 20th will be issued a $0.25 dividend. This is a boost from Pro Medicus’s previous Interim dividend of $0.18. This represents a dividend yield of 0.09%. The ex-dividend date of this dividend is Wednesday, February 26th. Pro Medicus’s dividend payout ratio is presently 56.41%.
Pro Medicus Company Profile
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
See Also
- Five stocks we like better than Pro Medicus
- What is the FTSE 100 index?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What is Forex and How Does it Work?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
- Bank Stocks – Best Bank Stocks to Invest In
- Analysts See Buying Opportunity in NVIDIA Before Earnings
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.